Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug market report explains the definition, types, applications, major countries, and major players of the Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Boehringer Ingelheim
Vetter
Porton
AbbVie Inc
Recipharm
WuXi AppTec
CMIC Group
Nectar Lifesciences
PCI
Grifols International, SA
Patheon
Asymchem
Lonza AG
Catalent
Almac Group
Aenova Group
By Type:
Blood Factors
Cytokines
Peptide Hormone
Immunoglobulin
Insulin
Other Drug Classes
By End-User:
Pharma Company
Biotech Company
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Outlook to 2028- Original Forecasts
-
2.2 Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market- Recent Developments
-
6.1 Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market News and Developments
-
6.2 Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Deals Landscape
7 Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Raw Materials and Cost Structure Analysis
-
7.1 Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Key Raw Materials
-
7.2 Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Price Trend of Key Raw Materials
-
7.3 Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Key Suppliers of Raw Materials
-
7.4 Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Concentration Rate of Raw Materials
-
7.5 Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Cost Structure Analysis
-
7.5.1 Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Raw Materials Analysis
-
7.5.2 Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Labor Cost Analysis
-
7.5.3 Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Manufacturing Expenses Analysis
8 Global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Import and Export Analysis (Top 10 Countries)
-
8.1 Global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Export by Region (Top 10 Countries) (2017-2028)
9 Global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Blood Factors Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Cytokines Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Peptide Hormone Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Immunoglobulin Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Insulin Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Other Drug Classes Consumption and Growth Rate (2017-2022)
-
9.2 Global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Pharma Company Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Biotech Company Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Analysis and Outlook till 2022
-
10.1 Global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.2.2 Canada Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.2.3 Mexico Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.3.2 UK Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.3.3 Spain Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.3.4 Belgium Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.3.5 France Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.3.6 Italy Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.3.7 Denmark Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.3.8 Finland Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.3.9 Norway Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.3.10 Sweden Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.3.11 Poland Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.3.12 Russia Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.3.13 Turkey Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.4.2 Japan Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.4.3 India Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.4.4 South Korea Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.4.5 Pakistan Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.4.6 Bangladesh Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.4.7 Indonesia Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.4.8 Thailand Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.4.9 Singapore Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.4.10 Malaysia Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.4.11 Philippines Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.4.12 Vietnam Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.5.2 Colombia Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.5.3 Chile Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.5.4 Argentina Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.5.5 Venezuela Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.5.6 Peru Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.5.7 Puerto Rico Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.5.8 Ecuador Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.6.2 Kuwait Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.6.3 Oman Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.6.4 Qatar Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.6.5 Saudi Arabia Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.6.6 United Arab Emirates Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.7.2 South Africa Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.7.3 Egypt Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.7.4 Algeria Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
-
10.8.2 New Zealand Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)
11 Global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Competitive Analysis
-
11.1 Boehringer Ingelheim
-
11.1.1 Boehringer Ingelheim Company Details
-
11.1.2 Boehringer Ingelheim Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Boehringer Ingelheim Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Main Business and Markets Served
-
11.1.4 Boehringer Ingelheim Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Vetter
-
11.2.1 Vetter Company Details
-
11.2.2 Vetter Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Vetter Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Main Business and Markets Served
-
11.2.4 Vetter Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Porton
-
11.3.1 Porton Company Details
-
11.3.2 Porton Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Porton Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Main Business and Markets Served
-
11.3.4 Porton Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 AbbVie Inc
-
11.4.1 AbbVie Inc Company Details
-
11.4.2 AbbVie Inc Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 AbbVie Inc Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Main Business and Markets Served
-
11.4.4 AbbVie Inc Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Recipharm
-
11.5.1 Recipharm Company Details
-
11.5.2 Recipharm Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Recipharm Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Main Business and Markets Served
-
11.5.4 Recipharm Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 WuXi AppTec
-
11.6.1 WuXi AppTec Company Details
-
11.6.2 WuXi AppTec Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 WuXi AppTec Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Main Business and Markets Served
-
11.6.4 WuXi AppTec Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 CMIC Group
-
11.7.1 CMIC Group Company Details
-
11.7.2 CMIC Group Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 CMIC Group Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Main Business and Markets Served
-
11.7.4 CMIC Group Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Nectar Lifesciences
-
11.8.1 Nectar Lifesciences Company Details
-
11.8.2 Nectar Lifesciences Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Nectar Lifesciences Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Main Business and Markets Served
-
11.8.4 Nectar Lifesciences Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 PCI
-
11.9.1 PCI Company Details
-
11.9.2 PCI Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 PCI Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Main Business and Markets Served
-
11.9.4 PCI Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Grifols International, SA
-
11.10.1 Grifols International, SA Company Details
-
11.10.2 Grifols International, SA Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Grifols International, SA Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Main Business and Markets Served
-
11.10.4 Grifols International, SA Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Patheon
-
11.11.1 Patheon Company Details
-
11.11.2 Patheon Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Patheon Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Main Business and Markets Served
-
11.11.4 Patheon Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Asymchem
-
11.12.1 Asymchem Company Details
-
11.12.2 Asymchem Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Asymchem Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Main Business and Markets Served
-
11.12.4 Asymchem Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Lonza AG
-
11.13.1 Lonza AG Company Details
-
11.13.2 Lonza AG Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Lonza AG Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Main Business and Markets Served
-
11.13.4 Lonza AG Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Catalent
-
11.14.1 Catalent Company Details
-
11.14.2 Catalent Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Catalent Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Main Business and Markets Served
-
11.14.4 Catalent Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Almac Group
-
11.15.1 Almac Group Company Details
-
11.15.2 Almac Group Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Almac Group Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Main Business and Markets Served
-
11.15.4 Almac Group Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Aenova Group
-
11.16.1 Aenova Group Company Details
-
11.16.2 Aenova Group Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Aenova Group Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Main Business and Markets Served
-
11.16.4 Aenova Group Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product Portfolio
-
11.16.5 Recent Research and Development Strategies
12 Global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Outlook by Types and Applications to 2028
-
12.1 Global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Blood Factors Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Cytokines Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Peptide Hormone Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Immunoglobulin Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Insulin Consumption Forecast and Growth Rate (2022-2028)
-
12.1.6 Global Other Drug Classes Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Pharma Company Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Biotech Company Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Analysis and Outlook to 2028
-
13.1 Global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.2.2 Canada Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.2.3 Mexico Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.3.2 UK Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.3.3 Spain Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.3.4 Belgium Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.3.5 France Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.3.6 Italy Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.3.7 Denmark Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.3.8 Finland Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.3.9 Norway Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.3.10 Sweden Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.3.11 Poland Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.3.12 Russia Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.3.13 Turkey Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.4.2 Japan Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.4.3 India Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.4.4 South Korea Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.4.8 Thailand Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.4.9 Singapore Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.4.11 Philippines Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.5.2 Colombia Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.5.3 Chile Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.5.4 Argentina Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.5.6 Peru Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.6.3 Oman Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.6.4 Qatar Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.7.2 South Africa Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.7.3 Egypt Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.7.4 Algeria Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug
-
Figure of Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Picture
-
Table Global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Blood Factors Consumption and Growth Rate (2017-2022)
-
Figure Global Cytokines Consumption and Growth Rate (2017-2022)
-
Figure Global Peptide Hormone Consumption and Growth Rate (2017-2022)
-
Figure Global Immunoglobulin Consumption and Growth Rate (2017-2022)
-
Figure Global Insulin Consumption and Growth Rate (2017-2022)
-
Figure Global Other Drug Classes Consumption and Growth Rate (2017-2022)
-
Figure Global Pharma Company Consumption and Growth Rate (2017-2022)
-
Figure Global Biotech Company Consumption and Growth Rate (2017-2022)
-
Figure Global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption by Country (2017-2022)
-
Table North America Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption by Country (2017-2022)
-
Figure United States Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure Canada Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure Mexico Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption by Country (2017-2022)
-
Figure Germany Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure UK Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure Spain Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure Belgium Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure France Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure Italy Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure Denmark Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure Finland Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure Norway Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure Sweden Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure Poland Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure Russia Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure Turkey Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Table APAC Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption by Country (2017-2022)
-
Figure China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure India Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure Thailand Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure Singapore Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure Philippines Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Table South America Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption by Country (2017-2022)
-
Figure Brazil Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure Colombia Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure Chile Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure Argentina Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure Peru Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Table GCC Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption by Country (2017-2022)
-
Figure Bahrain Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure Oman Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure Qatar Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Table Africa Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption by Country (2017-2022)
-
Figure Nigeria Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure South Africa Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure Egypt Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure Algeria Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Table Oceania Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption by Country (2017-2022)
-
Figure Australia Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)
-
Table Boehringer Ingelheim Company Details
-
Table Boehringer Ingelheim Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Main Business and Markets Served
-
Table Boehringer Ingelheim Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product Portfolio
-
Table Vetter Company Details
-
Table Vetter Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vetter Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Main Business and Markets Served
-
Table Vetter Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product Portfolio
-
Table Porton Company Details
-
Table Porton Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Porton Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Main Business and Markets Served
-
Table Porton Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product Portfolio
-
Table AbbVie Inc Company Details
-
Table AbbVie Inc Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Inc Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Main Business and Markets Served
-
Table AbbVie Inc Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product Portfolio
-
Table Recipharm Company Details
-
Table Recipharm Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Recipharm Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Main Business and Markets Served
-
Table Recipharm Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product Portfolio
-
Table WuXi AppTec Company Details
-
Table WuXi AppTec Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table WuXi AppTec Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Main Business and Markets Served
-
Table WuXi AppTec Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product Portfolio
-
Table CMIC Group Company Details
-
Table CMIC Group Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table CMIC Group Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Main Business and Markets Served
-
Table CMIC Group Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product Portfolio
-
Table Nectar Lifesciences Company Details
-
Table Nectar Lifesciences Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nectar Lifesciences Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Main Business and Markets Served
-
Table Nectar Lifesciences Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product Portfolio
-
Table PCI Company Details
-
Table PCI Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table PCI Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Main Business and Markets Served
-
Table PCI Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product Portfolio
-
Table Grifols International, SA Company Details
-
Table Grifols International, SA Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Grifols International, SA Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Main Business and Markets Served
-
Table Grifols International, SA Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product Portfolio
-
Table Patheon Company Details
-
Table Patheon Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Patheon Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Main Business and Markets Served
-
Table Patheon Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product Portfolio
-
Table Asymchem Company Details
-
Table Asymchem Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Asymchem Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Main Business and Markets Served
-
Table Asymchem Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product Portfolio
-
Table Lonza AG Company Details
-
Table Lonza AG Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lonza AG Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Main Business and Markets Served
-
Table Lonza AG Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product Portfolio
-
Table Catalent Company Details
-
Table Catalent Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Catalent Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Main Business and Markets Served
-
Table Catalent Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product Portfolio
-
Table Almac Group Company Details
-
Table Almac Group Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Almac Group Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Main Business and Markets Served
-
Table Almac Group Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product Portfolio
-
Table Aenova Group Company Details
-
Table Aenova Group Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aenova Group Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Main Business and Markets Served
-
Table Aenova Group Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product Portfolio
-
Figure Global Blood Factors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cytokines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Peptide Hormone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunoglobulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Insulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Drug Classes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharma Company Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biotech Company Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast by Country (2022-2028)
-
Table North America Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast by Country (2022-2028)
-
Figure Germany Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast by Country (2022-2028)
-
Figure China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast by Country (2022-2028)
-
Figure Brazil Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast by Country (2022-2028)
-
Figure Australia Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)
-
